DermTech, Inc.
DMTK · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $23,968 | $60,072 | $48,722 | $82,659 |
| - Cash | $27,579 | $36,741 | $37,230 | $42,790 |
| + Debt | $53,669 | $54,394 | $55,173 | $55,290 |
| Enterprise Value | $50,058 | $77,725 | $66,665 | $95,159 |
| Revenue | $3,845 | $3,924 | $3,915 | $3,980 |
| % Growth | -2% | 0.2% | -1.6% | – |
| Gross Profit | $713 | $440 | $172 | $8 |
| % Margin | 18.5% | 11.2% | 4.4% | 0.2% |
| EBITDA | -$19,102 | -$16,970 | -$18,467 | -$30,659 |
| % Margin | -496.8% | -432.5% | -471.7% | -770.3% |
| Net Income | -$20,010 | -$19,091 | -$19,164 | -$31,363 |
| % Margin | -520.4% | -486.5% | -489.5% | -788% |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 |
| % Growth | -3.6% | 1.8% | 42.4% | – |
| Operating Cash Flow | -$17,119 | -$12,707 | -$19,043 | -$23,201 |
| Capital Expenditures | $0 | $163 | -$49 | -$259 |
| Free Cash Flow | -$17,119 | -$12,544 | -$19,092 | -$23,460 |